NAT1 and breast cancer: As shown in Figure 1B, analysis of data from the TCGA database indicated that the expression of NAT1 mRNA was markedly decreased in COAD, kidney chromophobe, and rectum adenocarcinoma tissues compared with the corresponding normal tissues, but increased in those of breast cancer (P < 0.05).